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Transcatheter aortic valve replacement 
(TAVR) is a validated treatment option for patients 
presenting with severe aortic valve stenosis and 
intermediate/high surgical risk. Nevertheless, 
the procedure may lead to severe complications 
including coronary obstruction (CO). CO most 
frequently occurs within minutes after TAVR and, 
more rarely, up to several days after valve implan-
tation (delayed CO [DCO]) [1]. Reported herein 
a case of late DCO including a brief discussion of 
the current literature.
An 84-year old woman presented to the emer-
gency room in cardiogenic shock with severely 
depressed left ventricular ejection fraction (LVEF 
15%) due to anterior, apical and septal akinesia. 
Three months prior to this event, the patient 
had undergone transfemoral TAVR (Boston Sci-
entific Lotus, 25 mm) with the high implantation 
technique [2]. Before the procedure, coronary 
artery disease was ruled out and LVEF was 50%. 
The patient had to be stabilized with extensive 
medical hemodynamic support. The transesopha-
geal echocardiography showed an optimal TAVR 
device position without paravalvular leak and normal 
transvalvular gradient. A coronary angiogram was 
urgently performed showing subtotal ostial narrow-
ing of the left main coronary artery originating from 
the 25 mm Lotus-device with Thrombolysis in Myo-
cardial Infarction (TIMI) III flow in the left anterior 
descending, and circumflex arteries. The slit-like 
orifice seemed to be obstructed by calcific debris of 
the native valve which had pressed into the aortic 
sinus. A challenging but successful implantation 
of a drug-coated stent through the device meshes 
was performed (Coroflex ISAR 3.5 × 8 mm) after 
multiple angioplasties with non-compliant balloons. 
However, because of the elevated compression force 
the angiographic result was sub-optimal. There-
fore, in order to minimize the recoil a decision was 
made to implant a second stent (drug-eluting stent 
Xience 3.5 × 8 mm). In the current literature this 
practice is debatable and might increase the risk of 
deleterious effects, but the final outcome was good 
(Fig. 1). Catecholamines were rapidly discontinued 
and LVEF improved from 15% to 40%. At 6-month 
follow up no angina nor dyspnoea were detected, the 
patient was ambulatory and doing well.
Coronary obstruction is a rare, potentially 
dramatic complication of TAVR and the incidence of 
acute CO (within a few minutes from the procedure) 
is reported to be < 1% [1, 3–5]. The current litera-
ture provides limited clinical data regarding DCO. 
In a recent large series by Jabbour et al. [1] the 
incidence of DCO, both early and late (> 7 days), 
was 0.22% but might be under-diagnosed because 
of undetected cases and sudden cardiac deaths. 
Women are more often affected (50–83.3%) [1, 3] 
due to an anatomic predisposition, having a lower 
coronary height and smaller aortic sinus of Vals-
alva. The estimated risk cut off for the former is 
10–12 mm, while for the latter is 30 mm [1, 5, 6]. 
Moreover, a severe degree of calcification of the 
aortic valve apparatus is an important risk factor 
[1, 3, 7]. The valve-in-valve procedure is associa-
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ted with a higher risk of CO [1]. Data regarding 
association between valve type and CO are con-
tradictory: balloon-expandable devices were more 
often involved [3], but Jabbour et al. [1] in a recent 
large case-series reported a higher incidence with 
self-expandable devices possibly due to persistent 
expansion.
Clinical presentation of DCO is heterogene-
ous, ranging from stable angina and ventricular 
arrhythmias to acute myocardial infarction and 
cardiac arrest [1, 3]. Severe and persistent hypo-
tension after the TAVR procedure, not necessar-
ily associated with electrocardiogram changes, 
may be a leading symptom [2]. Left main artery 
is most often involved (83.3–92.1%) compared to 
the right coronary artery (12.5–26.3%) [1, 3]. The 
underlying pathogenetic events triggering CO are 
multiple: thrombotic embolism, obstruction due to 
native or bioprosthesis valve leaflets, mechanical 
obstruction by the valve strut or calcium disloca-
tion [1, 5, 6, 8]. In many cases however, the etiology 
remains unclear.
The overall mortality rate in hospitalized 
patients is up to 50%. Urgent percutaneous coro-
nary intervention is recognized to be the favored 
treatment strategy with a successful outcome 
in 74.3–91.3% of cases [1, 3, 4]. In a systematic 
review by Ribeiro et al. [3] 13.4% of the patients 
required implantation of a second stent (stent-in-
stent) because of persistent and elevated compres-
sion. In stable clinical settings, coronary computed 
tomography angiography maybe considered the 
first line option to rule out CO [1].
Clinical suspicion and history of TAVR should 
be taken into account for early recognition of 
DCO. Stent implantation through the meshes of 
the biological valve is a high risk and challenging 
procedure but can lead to a successful outcome. 
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Figure 1. Coronary angiogramm showing a slit like narrowing of the ostial left main originating and final result after 
complex percutaneous coronary intervention with stent-in-stent implantation.
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